Online inquiry

IVTScrip™ mRNA-Human AGAP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK14388MR)

This product GTTS-WK14388MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AGAP2 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001122772.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 116986
UniProt ID Q99490
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AGAP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK14388MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK17327MR IVTScrip™ mRNA-Human ANKRD45, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ANKRD45
GTTS-WK28639MR IVTScrip™ mRNA-Human ARL2BP, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARL2BP
GTTS-WK1148MR IVTScrip™ mRNA-Human CD71, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA CD71
GTTS-WK11573MR IVTScrip™ mRNA-Human ACTR3B, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ACTR3B
GTTS-WK25283MR IVTScrip™ mRNA-Human ARHGAP15, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP15
GTTS-WK10280MR IVTScrip™ mRNA-Human ABLIM3, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ABLIM3
GTTS-WK11292MR IVTScrip™ mRNA-Human ADAM19, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADAM19
GTTS-WK27463MR IVTScrip™ mRNA-Human ARNTL, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARNTL
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →